Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares are trading lower on Tuesday after getting a downgrade.
RBC analysts downgraded the company's stock from Outperform to Sector Perform.
Vertex is a biopharmaceutical company based in Boston, Massachusetts.
Vertex shares were trading down 4.64% at $256.04 at time of publication on Tuesday. The stock has a 52-week high of $277.80 and a 52-week low of $164.07.
Related Link:
Vertex To Acquire Diabetes Treatment Company Semma Therapeutics For $950M
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
